Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?
Cumbo C, Orsini P, Tarantini F, Anelli L, Zagaria A, Tragni V, Coccaro N, Tota G, Parciante E, Conserva MR, Redavid I, Minervini CF, Minervini A, Attolico I, Gentile M, Pierri CL, Specchia G, Musto P, Albano F. Cumbo C, et al. Among authors: attolico i. Hematol Oncol. 2023 Dec;41(5):942-946. doi: 10.1002/hon.3212. Epub 2023 Aug 3. Hematol Oncol. 2023. PMID: 37534633
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.
Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S, Sista MT, Sofritti O, Rizzotto L, Sabattini E, Fioritoni G, Falorio S, Stelitano C, Olivieri A, Attolico I, Brugiatelli M, Zinzani PL, Saccenti E, Capello D, Negrini M, Cuneo A, Pileri S. Ciccone M, et al. Among authors: attolico i. Leukemia. 2012 Mar;26(3):499-508. doi: 10.1038/leu.2011.247. Epub 2011 Sep 23. Leukemia. 2012. PMID: 21941366
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
Attolico I, Pavone V, Ostuni A, Rossini B, Musso M, Crescimanno A, Martino M, Iacopino P, Milone G, Tedeschi P, Coluzzi S, Nuccorini R, Pascale S, Di Nardo E, Olivieri A. Attolico I, et al. Biol Blood Marrow Transplant. 2012 Feb;18(2):241-9. doi: 10.1016/j.bbmt.2011.07.014. Epub 2011 Jul 24. Biol Blood Marrow Transplant. 2012. PMID: 21791194 Free article. Clinical Trial.
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
Caocci G, Mulas O, Abruzzese E, Luciano L, Iurlo A, Attolico I, Castagnetti F, Galimberti S, Sgherza N, Bonifacio M, Annunziata M, Gozzini A, Orlandi EM, Stagno F, Binotto G, Pregno P, Fozza C, Trawinska MM, De Gregorio F, Cattaneo D, Albano F, Gugliotta G, Baratè C, Scaffidi L, Elena C, Pirillo F, Scalzulli E, La Nasa G, Foà R, Breccia M. Caocci G, et al. Among authors: attolico i. Hematol Oncol. 2019 Aug;37(3):296-302. doi: 10.1002/hon.2606. Epub 2019 Apr 17. Hematol Oncol. 2019. PMID: 30892724 Free PMC article.
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment.
Tarantini F, Anelli L, Ingravallo G, Attolico I, Zagaria A, Russo Rossi A, Lospalluti L, Bufano T, Zanframundo G, Maiorano E, Specchia G, Albano F. Tarantini F, et al. Among authors: attolico i. Cancer Manag Res. 2019 Aug 26;11:7991-7996. doi: 10.2147/CMAR.S217872. eCollection 2019. Cancer Manag Res. 2019. PMID: 31692557 Free PMC article.
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele.
Anelli L, Orsini P, Zagaria A, Minervini A, Coccaro N, Parciante E, Minervini CF, Cumbo C, Tota G, Impera L, Conserva MR, Redavid I, Tarantini F, Ricco A, Attolico I, Specchia G, Albano F. Anelli L, et al. Among authors: attolico i. Leukemia. 2021 Feb;35(2):619-622. doi: 10.1038/s41375-020-0847-4. Epub 2020 May 4. Leukemia. 2021. PMID: 32366936 No abstract available.
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.
Latagliata R, Attolico I, Trawinska MM, Capodanno I, Annunziata M, Elena C, Luciano L, Crugnola M, Bergamaschi M, Bonifacio M, Baratè C, Mauro E, Binotto G, Sgherza N, Aguzzi C, Monteleone B, Sorà F, Caocci G, Luzi D, Mariggiò E, Scaffidi L, Cattaneo D, Gozzini A, Di Veroli A, Abruzzese E, Galimberti S, Iurlo A, Specchia G, Breccia M. Latagliata R, et al. Among authors: attolico i. Hematol Oncol. 2021 Aug;39(3):401-408. doi: 10.1002/hon.2851. Epub 2021 Mar 13. Hematol Oncol. 2021. PMID: 33617659
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.
Cumbo C, Tota G, De Grassi A, Anelli L, Zagaria A, Coccaro N, Tarantini F, Minervini CF, Parciante E, Impera L, Conserva MR, Redavid I, Mestice A, Attolico I, Pierri CL, Musto P, Albano F. Cumbo C, et al. Among authors: attolico i. Leuk Lymphoma. 2023 Mar;64(3):717-721. doi: 10.1080/10428194.2021.1929960. Epub 2021 May 24. Leuk Lymphoma. 2023. PMID: 34027815 No abstract available.
44 results